Stay updated on INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page.

Latest updates to the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has been updated to reflect a new version of the clinical trial for Urothelial Carcinoma, with the removal of detailed trial descriptions and criteria, and the addition of a new revision date and trial identifier.SummaryDifference29%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 21, 2025.SummaryDifference0.2%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check44 days agoChange DetectedThe webpage has updated its date references, removing older dates from February 2025 and adding new dates in March 2025.SummaryDifference0.6%
- Check73 days agoChange DetectedThe webpage has updated its date listings to include new dates in February 2025, while removing older dates from January 2025. Additionally, a notice regarding service performance and availability has been removed.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INO-5401+INO-9012+Atezolizumab in Urothelial Carcinoma Clinical Trial page.